Shortage of drugs to ensure supply and price stabilization. Recent work has been announced. Supervision and law enforcement have been stepped up

Screenshot of the official website of the National Health Commission

People's Daily Online, Beijing, May 27 (Zhang Wenting) The ability and level of supply guarantee for shortage of medicines are constantly improving.

It is understood that since 2021, the national and provincial two-level drug shortage supply guarantee work consultation linkage mechanism leading department will work with relevant units to implement the national shortage drug list and the clinically necessary and easily shortage drugs key monitoring list drugs (hereinafter referred to as "National List Drugs" ") As the focus on protection, we will continue to promote the supply of shortage drugs from four aspects.

Fully implement the management policy of the shortage drug list

On the basis of issuing the "National List of Drugs", the National Health Commission has issued the "Notice on Doing a Good Job in Key Monitoring and Supply Assurance of National Listed Drugs", emphasizing the follow-up and evaluation of policies and measures and other related work.

Promote the construction of information management of shortage drugs

The State Food and Drug Administration will mark the approval number data of the "National List of Drugs", set up a column for shortage of drugs, and build a module for collecting information on the production and supply of shortage of drugs and the report of discontinuation of production.

Go all out to ensure the supply of key drugs

The State-owned Assets Supervision and Administration Commission of the State Council instructed China National Pharmaceutical Group Co.

Further increase supervision and law enforcement

First of all, severely investigate and punish all types of illegal drug sales.

In addition, comprehensively implement the construction of medical prices and credit evaluation systems for recruitment and procurement.